@article{2444553f65404e78aa20776bb334e8f5,
title = "Response by Pfeffer et al to Letter Regarding Article, {"}heart Failure with Preserved Ejection Fraction in Perspective{"}",
author = "Pfeffer, {Marc A.} and Shah, {Amil M.} and Borlaug, {Barry A.}",
note = "Funding Information: M.A. Pfeffer receives research support from Novartis. He serves as a consultant for AstraZeneca, Corvidia, DalCor, GlaxoSmithKline, Novartis, Novo Nordisk, Roche, Sanofi, Servier and Takeda and has equity in DalCor. A.M. Shah is supported by National Institutes of Health/National Heart, Lung, and Blood Institute grants K08HL116792, R01HL135008, and R01HL143224. He receives research support through Brigham and Women{\textquoteright}s Hospital from Novartis. He serves as a consultant from Bellerophon Therapeutics and Philips Ultrasound. B.A. Borlaug is supported by the National Institutes of Health (R01 HL128526). The other authors report no conflicts.",
year = "2019",
month = aug,
day = "2",
doi = "10.1161/CIRCRESAHA.119.315591",
language = "English (US)",
volume = "125",
pages = "E26",
journal = "Circulation research",
issn = "0009-7330",
publisher = "Lippincott Williams and Wilkins",
number = "4",
}